Category Archives: Stem Cell Therapy

Andre Goy, MD, chairman, director, and chief of the Division of Lymphoma at John Theurer Cancer Center in Hackensack, NJ, discussed the potential benefits of using CAR T-cell therapies as a second-line treatment.

Andre Goy, MD, chairman, director, and chief of the Division of Lymphoma at John Theurer Cancer Center in Hackensack, NJ, discussed the potential benefits of using CAR T-cell therapies as a second-line treatment.

Transcript

After the approval of the first CAR T-cell therapies there was a discussion at ASCO about whether these therapies should be used earlier, when they might be more effective. What is the current thinking on this issue?

It is a very important aspect of CAR T-cell therapy because it is a game changer. And roughly 30-40% of patients have long-term benefits, particularly in aggressive lymphoma. That's sort of a main focus today. And what that means is that they're still 2 thirds of the patients who don't necessarily benefit or relapse after CAR T.

So, the question is how we can improve the concept of T-cell fitness and lessen the exposure to biochemotherapy for T-cells and the immune system. That seems to be very important. There're additional biomarkers, the inflammatory [garbled] prior to CAR T-cells that affects the response as well.

The next step is, because we've seen some activity in patients who have failed multiple lung therapy, can we actually take advantage of the CAR T-cell therapy earlier. To answer your question, there are ongoing trials that are looking at using CAR T, instead as a third line, like it is approved now, as a second line randomization versus an autologous stem cell transplant. All of these trials are being completed, like ZUMA-7. But there's also ongoing trials, that are looking at exactly the same question, to see if we can we actually improve the outcome of patients with larger lymphoma relapse, where we know with autologous stem cell transplantation, particularly in the early failure primary factory, has a very small percentage of long-term good outcome, using CAR T-cell therapy? So, there will be data at ASH's [American Society of Hematology] Annual Meeting. And some of these clinical trials are still ongoing, but it is very promising to try to bring a CAR T-cell earlier and improve the outcome in these patients.

Read the original:
Dr Andre Goy Discusses Potential Benefits of Earlier Use of CAR T Therapies - AJMC.com Managed Markets Network

Brian T. Hill, MD, PhD, discusses next steps for research examining CAR T-cell therapy in mantle cell lymphoma.

Brian T. Hill, MD, PhD, director of the Lymphoid Malignancies Program and staff physician at Taussig Cancer Institute, as well as an assistant professor of Hematology and Oncology at the Cleveland Clinic, discusses next steps for research examining CAR T-cell therapy in mantle cell lymphoma (MCL).

Two questions regarding the use of CAR T-cell therapy in MCL involve moving the therapy up into earlier lines of treatment and using it in combination with other agents, says Hill. Thus far, there have been no compelling reasons to combine other therapies with CAR T-cell treatment for lymphoma,Hill explains. However, studies are looking into this concept, adds Hill.

In terms of using CAR T-cell therapy in earlier lines of treatment, many ongoing discussions are focused on examining the use this approach in certain populations with high-risk disease, according to Hill. These populations includethose with TP53 mutations or a blastoid variant of MCL, a subtype that has historically yielded particularly poor outcomes with traditional chemotherapy and high-dose chemotherapy, as is used in autologous stem cell transplant, concludes Hill.

Read more here:
Dr. Hill on Next Steps for Research Exploring CAR T-Cell Therapy in MCL - OncLive

PITTSBURGH, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Those who are looking for an alternative treatment option when compared to traditional medicine are now in luck. Recently, World Wide Stem Cell Treatment Centers announced that it was opening the first of its more than 300 planned locations all over the world. With access to a wide range of treatment options, it is possible for patients to visit World Wide Stem Cell Treatment Centers and enjoy a more comprehensive recovery process than they ever have in the past. Therefore, it is important to highlight some of the major benefits that come with visiting World Wide Stem Cell Treatment Centers or health treatment options.

An Introduction to World Wide Stem Cell Treatment Centers: The First Location is Open

Right now, the first location has opened for World Wide Stem Cell. This treatment center location is in Pittsburgh, Pennsylvania. Currently, more than 300 locations are scheduled to open worldwide.

In many situations, treatment options from World Wide Stem Cell can actually work very well when working in combination with traditional medical therapy. The goal of World Wide Stem Cell Treatment Centers is to provide patients with more options, allowing them to tailor their treatment options to meet their individual needs and avoid invasive surgery whenever possible. In this manner, patients can work with the professionals at World Wide Stem Cell to develop a custom treatment plan to meet their unique needs.

Who Might Need Stem Cell Therapy from World Wide Stem Cell Treatment Centers?

The reality is that anyone is able to benefit from stem cell therapy from World Wide Stem Cell. At the same time, it is also important for people to know what goes into stem cell therapy.

First, one of the most common patient populations that might benefit from a visit to World Wide Stem Cell is athletes who have suffered an injury. While participating in their sport. While sports are great for conditioning and staying in shape. Injuries are always a very real risk. When an athlete suffers an injury, World Wide Stem Cell is able to treat that athlete and in most cases have that athlete participating back in his sport again in up to 1/10th of the time without invasive surgery. So with that being said the entire population at one time or another are candidates for stem cells. Whether it be a knee, hip, shoulder or any other orthopedic joint. Stem cells in most cases are able to replace invasive surgery; with a stem cell injection. World Wide Stem Cell always treats every condition with the proper cells for that particular situation. We only use orthopedic surgeons and neurosurgeons that do all our injections and they are all done with ultrasound guided needle injections. Whether you are interested in orthopedic treatments, facial rejuvenation, anti-aging cells, hair replacement, erectile dysfunction. We have them all at World Wide Stem Cell. Call, email, inquire!

Contact:

300 Chapel Harbor DriveSuite 204Pittsburgh, Pa 15238Contact: JS Genslinger (founder)412-408-3183

See original here:
World Wide Stem Cell Treatment Centers Provides Exceptional Regenerative Treatment Options To Those in Need - GlobeNewswire

In a recent clinical trial for an immune cell therapy for lymphoma, 62% of patients experienced complete cancer clearance in spite of the fact that some of them were on their 5th line of treatment. Stem cell therapies have the potential to enact more of these paradigm-shifting treatments. Proposition 14 will continue to advance these therapies and bring them to full development as available cures.

The vision of stem cell therapy is that a physician can just as easily grab an IV bag full of therapeutic cells as they might draw a drug into a syringe. Conceived through Proposition 71 in 2004, the California Institute for Regenerative Medicine (CIRM) serves as a vehicle to support all aspects of stem cell research. Medical progress requires not just well-designed clinical studies but also a well-trained workforce, educated at the intersection of stem cell biology, engineering, and chemistry.

Since 2008, CIRM has supported the training of nearly 1300 Community College and California State University students for the emerging field of Regenerative Medicine through the Bridges to Stem Cell Research and Therapy Program. The Bridges Training Program has functioned as a pathway for first-generation and underrepresented students from Humboldt to San Diego, to all of the biomedical sectors startup and cell therapy companies, academic research institutes, graduate and medical school, and more. Exposure to hands-on labs, advanced seminar discussions, and a required paid internship fully prepares these students for entering the stem cell workforce. Over 80% of Bridges alumni have either advanced to graduate school or joined the biomedical workforce in industry or academic institutions. These Programs bring a greater return than the initial cost of training.

SPONSORED

Consider Vahid Hamzeinejad, a bright high school student, headed to UC Berkeley to begin his college career. Enter the Great Recession; Vahid found himself back at home, working non-stop to help keep his parents restaurant afloat. Not giving up on his commitment to an education, he enrolled at the College of the Canyons. After completing an Associates degree, Vahid transferred to Cal Poly, hoping to join the Bridges Program. After receiving the Bridges core training, Vahid started his internship at ViaCyte, where he continues to work today, as a critical member of the team supporting ViaCytes clinical development of a functional cure for diabetes. The nearly $30 billion that California currently spends on diabetes treatments could be significantly reduced, in no small part due to the efforts of a student that cost taxpayers $36,000 to educate. That is before considering the benefit to patients quality of life that would occur by replacing insulin pumps, glucose monitors, and constant vigilance with a stem-cell-derived tissue that regulates blood sugar levels biologically making and secreting its own insulin.

Passing Proposition 14 will enable this and other unparalleled treatments for diabetes, heart disease, cancer, and neurological disorders.

Signed,

Robert Kam and the CIRM Bridges Program

SPONSORED

Read the original here:
CIRM Bridges to Stem Cell Research & Therapy The Bridge to Everywhere (in biomedicine) OP-ED - The Silicon Valley Voice

Reportspedia has recently come up with a new market research report titled, Stem Cell Therapy Market. This statistical market study compromises an extensive understanding of the present-day and impending stages of the industry market based on factors such as major research skills, management schemes, drivers, restraints, opportunities, challenges, and visions include the subdivisions in the industries and regional distribution. Besides, this report emphasizes the latest events such as technological developments and product launches and their consequences on the Market. The research report delivers the global market revenue, parent market trends along with market attractiveness per market segment.

Get a Sample Copy of this [emailprotected]:

https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#request_sample

Top Key Players:

Celgene CorporationOsiris Therapeutics, Inc.Pharmicell Co., LtdMEDIPOST Co., Ltd.Promethera BiosciencesFibrocell Science, Inc.Holostem Terapie Avanzate S.r.l.Cytori TherapeuticsNuvasive, Inc.RTI Surgical, Inc.Anterogen Co., Ltd.RTI Surgical, Inc

Regional Stem Cell Therapy Market (regional production, demand, and forecast by country):

The market specialists and researchers have done an all-encompassing breakdown of the global Stem Cell Therapy Market with the benefit of research methodologies such as PESTLE and Porters Five Forces analysis. They give precise and reliable market data and helpful recommendations with a means to support the players gain an insight into the overall current and upcoming market scenario. The report provides key statistics on the market status, size, share, growth factors of the Global Stem Cell Therapy industry.

Get Discount on This Precious Report @:

https://www.reportspedia.com/discount_inquiry/discount/57925

The main goals of the research report elegant the overall market overview on Stem Cell Therapy market dynamics, historic volume and value, newest and upcoming trends, Porters Five Forces Analysis, cost structure, government policies, and regulations, etc.

KEY MARKET SEGMENTS

On the basis of types, the Stem Cell Therapy Market is primarily split into:

Adult Stem CellsHuman EmbryonicInduced Pluripotent Stem CellsVery Small Embryonic Like Stem Cells

On the basis of applications, the Stem Cell Therapy Market covers:

Regenerative MedicineDrug Discovery and Development

This research report represents a 360-degree overview of the competitive landscape of the Meat Ingredients Market. Likewise, it offers enormous data relating to current trends, technological advancements, tools, and methodologies. The Stem Cell Therapy report thoroughly upholds the up-to-date state of dynamic segmentation of the Stem Cell Therapy Industry, highlighting major and revenue efficient market segments comprising the application, type, technology, and the like that together coin lucrative business returns in the Stem Cell Therapy market.

Inquiry Before [emailprotected]:

https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#inquiry_before_buying

Key Pointers of the Report:

Table of Contents

Global Stem Cell Therapy Market Research Report

Chapter 1 Stem Cell Therapy Market Overview

Chapter 2 Global Economic Impact on Stem Cell Therapy

Chapter 3 Global Stem Cell Therapy Market Competition by Key Players

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Stem Cell Therapy Industry Analysis by Application, Type

Chapter 6 Stem Cell Therapy Market Manufacturing Cost Analysis

Chapter 7 Marketing Strategy Analysis, Distributors/Traders

Chapter 9 Market Effect Factors Analysis

Chapter 9 Global Stem Cell Therapy Market Forecast

Get Full Table of content @:

https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#table_of_contents

Read the original:
Global Stem Cell Therapy Market 2020: Trends, and Opportunity Analysis, Top Manufacturers And Forecast to 2027 - PRnews Leader

The study on Adipose Tissue-derived Stem Cell Therapy market provides thorough insights pertaining to major growth drivers, challenges, and opportunities that will influence the industry expansion in the forthcoming years.

According to the research document, the industry is expected to register XX% CAGR over the forecast period (2020-2025), subsequently accruing significant gains by the end of analysis timeframe.

The market is in a disarray due to the lockdowns imposed for limiting the spread of COVID-19 outbreak. In addition to the sudden slump of revenue, some businesses are expected to tackle a plethora of challenges post the pandemic.

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/224665

Most of the businesses across various sectors have renewed their budgets to focus on profit gains in upcoming years. Our comprehensive analysis of the business sphere can help stakeholders in making sound decisions to compensate for market uncertainties and support them in building strong contingency plans.

Further, the report provides a granular assessment of the several industry segmentations to convey a deeper understanding of the areas with strong profit potential.

Key inclusions of the Adipose Tissue-derived Stem Cell Therapy market report:

Adipose Tissue-derived Stem Cell Therapy Market segments covered in the report:

Regional segmentation:

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Product types: Autologous Stem Cells and Allogeneic Stem Cells

Applications spectrum: Therapeutic Application and Research Application

Competitive outlook:

Our Market Research Solution Provides You Answer to Below Mentioned Question:

Which are the key factors driving the growth of the industry?

What are the emerging market trends and opportunities for this sector?

What is the future growth trend of this industry?

What is the size of the global and regional sector in terms of volume, size, and revenue?

Which is the most promising region in the global market?

What is the forecasted revenue and volume growth rates of the industry in the coming years?

Which region holds the highest share and what are the market shares of other key regions?

How will each segment and region grow over the years until 2025?

Table of Contents:

Report Overview: It includes major players of the global Adipose Tissue-derived Stem Cell Therapy market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Market Share by Manufacturers: Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Production by Region: Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region: This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Market Size by Type: This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application: Besides an overview of the global Adipose Tissue-derived Stem Cell Therapy market by application, it gives a study on the consumption in the global Adipose Tissue-derived Stem Cell Therapy market by application

Company Profiles: Almost all leading players of the global Adipose Tissue-derived Stem Cell Therapy market are profiled in this section. The analysts have provided information about their recent developments in the global Adipose Tissue-derived Stem Cell Therapy market, products, revenue, production, business, and company.

Key Findings: This section gives a quick look at important findings of the research study.

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/224665

Read the original post:
Adipose Tissue-derived Stem Cell Therapy Market: Worldwide Industry to Boost in the Period of 2020-2025 - Express Journal